Bupropion Hydrochloride
Product Images NDC 10370-204

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 10370-204). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Par Pharmaceutical, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Molecular-structure (Bpp Sr Z 1)

Chemical structure of Bupropion Hydrochloride. The structure shows a chlorophenyl ring attached to a ketone group and a tert-butylamino group, with a hydrochloride component indicated separately.*

FDA Label Image

Bottle-labeling-150mg (Bpp Sr Z 2)

Label for Bupropion Hydrochloride Extended-Release Tablets USP (SR) 150 mg by Par Pharmaceutical, Inc. The label indicates a twice-a-day dosage, 60 tablets per bottle, with warnings against use with Wellbutrin and related products. Storage instructions specify controlled room temperature, and the label includes a barcode and dosing cautions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.